# PHASE 14 FINAL REPORT

## Status
PARTIAL

## Repository Baseline

- Starting commit: `d763ee2217305e28663d2c0d680fed95ceb85a54`
- Branch: `main`
- `origin/main` matched the starting commit.
- Pre-existing uncommitted work included audit/migration/dbumi/test changes, Phase 13 shell files, and the untracked `query` file containing `MariaDB`. It was preserved.

## Runtime Certification

The runner now supports `tests/run.php --group=<name>` and writes timestamp, PID, memory, and last completed test function markers to the system temporary trace file. `tests/certify.php` records child group exit codes and classifies exit `259` as environment termination.

Observed grouped results include database `19/19`, modules `14/14`, auth `19/19`, and Pharmacy `23/23` in completed runs. Other attempts terminate with Windows exit `259`, including during setup/registration, without PHP assertion output. The trace markers show completed groups before termination. This supports an intermittent PHP/XAMPP/Windows process issue, not a deterministic application assertion failure. Ten consecutive complete certification runs were **NOT achieved**.

## Test Groups

- Database: 19 passed, 0 failed in a completed run.
- Modules: 14 passed, 0 failed in a completed run.
- Auth: 19 passed, 0 failed in a completed run.
- Pharmacy: 23 passed, 0 failed in a completed run.
- Full certification: **PARTIAL**, because exit `259` remains reproducible.

## Pharmacy Authorization

Added `core/permissions/legacy-route-guard.php`. It requires the Unified acting identity, resolves the bridged Pharmacy store, and reuses existing tenant-scoped Pharmacy permissions and Super Admin bypass behavior.

Protected pages include products, POS, stock, customers, suppliers, purchases, payments, expenses, and damage. Protected mutation endpoints include customer, supplier, supply, product, damage, expense, purchase invoice, sales invoice, payment, and return actions. Direct URL and guard allow/deny logic are covered by the Pharmacy employee identity test. Comprehensive browser HTTP denial testing remains **NOT TESTED**.

## Tenant Isolation

The bridge checks the store's owning tenant through `p_tenant_bridge` and passes that tenant into the existing permission service. Existing cross-tenant Pharmacy identity tests pass in completed grouped runs. Forged browser IDs and every AJAX endpoint remain **PARTIALLY TESTED**.

## Dashboard/UI

The shared shell in `core/dashboard/` provides fixed topbar/sidebar/footer, scrollable content, desktop collapse persistence, mobile off-canvas behavior, tenant branding, Unified user identity, search entry, notification count, and logout. Profile/settings links to unfinished routes were removed. Desktop/mobile browser validation is **NOT TESTED** in this session.

## Currency Integration

Existing CORE currency services remain authoritative. The shell does not alter stored amounts or introduce hardcoded currency formatting. Representative browser display validation is **DEFERRED**.

## Notifications

Added tenant/user-scoped unread count and recent notification queries plus a shared notification page. No notification fixtures were added to production. Runtime notification isolation testing is **NOT TESTED**.

## Search

The existing module-aware Pharmacy provider remains permission and tenant/store scoped. Search runtime validation is **PARTIALLY TESTED** through existing provider code; browser validation is **NOT TESTED**.

## Database

No new migration was required. Completed disposable checks verify 34 tables, 65 foreign keys, 5 migrations, and dbumi structural consistency. The migration runner uses statement-by-statement execution for the Windows instability mitigation.

## Pharmacy Compatibility

Existing legacy pages, Pharmacy schema, POS, product, stock, customer, supplier, purchase, payment, expense, damage, report, and bridge code were preserved. Pharmacy schema grouped checks completed successfully in observed runs.

## Security

Repository-wide PHP lint passes. Disposable database names require `test` and reject exact `pharmacy`, `production`, `prod`, and `live`. Existing CSRF, SQL-injection, session, currency, payment, transaction, and audit tests remain available. New guard tests cover granted and ungranted permissions. Full direct-route/AJAX HTTP security testing is **PARTIALLY TESTED**.

## Production Database Safety

The real database named `pharmacy` was not modified. It was checked only for existence and table count; destructive operations targeted generated test-only databases.

## Git

No commit or push was performed in this continuation. The worktree contains legitimate Phase 13/14 changes and the pre-existing untracked `query` artifact. Final HEAD remains `d763ee2`; `origin/main` remains `d763ee2`. Working tree is **not clean**.

## Remaining Risks

- Windows PHP/XAMPP exit `259` remains intermittently reproducible.
- Browser visual and HTTP validation was not completed.
- Legacy route/action authorization coverage is broad but not exhaustive.
- Profile/settings UI is deferred.
- Ten-run certification target was not achieved.

## Recommendation for Phase 15

Do not begin Phase 15. Complete browser validation, exhaustive route/action authorization tests, and a repeatable certification environment first.
